Semaglutide Reduces Body Fat in Obese Diabetes Patients Regardless of Formulation
Both oral and subcutaneous semaglutide significantly reduced fat mass and improved metabolic parameters in obese type 2 diabetes patients over 24 weeks.
Quick Facts
What This Study Found
Both oral and subcutaneous semaglutide significantly reduced fat mass and improved metabolic parameters in adults with obesity and type 2 diabetes over 24 weeks.
Key Numbers
24-week study in adults with type 2 diabetes and BMI ≥ 30 kg/m². Both daily oral and weekly subcutaneous semaglutide were used. Body composition measured by bioelectrical impedance analysis.
How They Did This
24-week quasi-experimental retrospective study using bioelectrical impedance analysis to measure body composition changes.
Why This Research Matters
Knowing that semaglutide reduces fat specifically — not just total weight — is important because fat loss drives the metabolic health benefits, while muscle preservation maintains function and metabolism.
The Bigger Picture
Knowing semaglutide reduces fat specifically (not just weight) and that this occurs with both oral and injectable forms helps patients and doctors choose the most appropriate formulation without worrying about differential body composition effects.
What This Study Doesn't Tell Us
Retrospective study design without randomization to oral versus subcutaneous groups. Bioelectrical impedance is less precise than DEXA scanning for body composition.
Questions This Raises
- ?Does one formulation produce better fat loss than the other?
- ?Would longer treatment duration show continued fat loss or a plateau?
Trust & Context
- Key Stat:
- Both formulations effective Daily oral and weekly subcutaneous semaglutide both significantly reduced fat mass, not just total weight
- Evidence Grade:
- Rated moderate: quasi-experimental retrospective study with body composition data, but non-randomized comparison between oral and subcutaneous groups.
- Study Age:
- Published in 2024. Adds body composition data to the growing evidence base for semaglutide in both formulations.
- Original Title:
- Transforming body composition with semaglutide in adults with obesity and type 2 diabetes mellitus.
- Published In:
- Frontiers in endocrinology, 15, 1386542 (2024)
- Authors:
- Rodríguez Jiménez, Beatriz, Rodríguez de Vera Gómez, Pablo, Belmonte Lomas, Samuel, Mesa Díaz, Ángel Manuel, Caballero Mateos, Irene, Galán, Irene, Morales Portillo, Cristóbal, Martínez-Brocca, María Asunción
- Database ID:
- RPEP-09164
Evidence Hierarchy
Frequently Asked Questions
Does semaglutide reduce fat or muscle?
This study confirmed semaglutide primarily reduces fat mass, not just total weight, using body composition analysis.
Does the oral pill work as well as the injection?
Both forms produced significant fat mass reduction and metabolic improvement over 24 weeks.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09164APA
Rodríguez Jiménez, Beatriz; Rodríguez de Vera Gómez, Pablo; Belmonte Lomas, Samuel; Mesa Díaz, Ángel Manuel; Caballero Mateos, Irene; Galán, Irene; Morales Portillo, Cristóbal; Martínez-Brocca, María Asunción. (2024). Transforming body composition with semaglutide in adults with obesity and type 2 diabetes mellitus.. Frontiers in endocrinology, 15, 1386542. https://doi.org/10.3389/fendo.2024.1386542
MLA
Rodríguez Jiménez, Beatriz, et al. "Transforming body composition with semaglutide in adults with obesity and type 2 diabetes mellitus.." Frontiers in endocrinology, 2024. https://doi.org/10.3389/fendo.2024.1386542
RethinkPeptides
RethinkPeptides Research Database. "Transforming body composition with semaglutide in adults wit..." RPEP-09164. Retrieved from https://rethinkpeptides.com/research/rodriguez-2024-transforming-body-composition-with
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.